Basel, June 26, 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the CE-IVD launch of its automated digital pathology algorithm, the uPath PD-L1 (SP263) image analysis for non-small cell lung ...
Roche has launched a new version of its digital pathology platform in Europe, with a CE-IVD mark for an artificial-intelligence-powered image analysis algorithm aimed at non-small cell lung cancer.
BOSTON, March 9, 2023 /PRNewswire/ -- PathAI, a global leader in AI-powered pathology, today announced the launch of AISight™, PathAI's digital pathology platform, and the AIM-PD-L1 NSCLC RUO ...
SEOUL, South Korea, Jan. 31, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), in partnership with leading precision oncology company Guardant Health, today announced the integration of its AI-based PD-L1 ...
uPath PD-L1 (SP263) image analysis uses automated pre-computing and one-click scoring to enable quicker and accurate detection and measurement of tumour cell staining positivity Roche advances ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback